CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 28 enrolled
Drug / intervention
DWCZP +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01654601
NCT01654601Phase 1Completed
CompareCT.gov

Clinical Trials to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg After a Multi-dose Oral Administration in Schizophrenia Patients

Dong Wha Pharmaceutical Co. Ltd.·interventional·Posted Aug 1, 2012·Updated Mar 27, 2017

In Brief

A Phase 1 clinical trial evaluating DWCZP and Clozaril for Schizophrenia. Completed, enrolled 28 participants across 5 sites.

Detailed Summary

To evaluate the pharmacokinetics of oral multiple-dose of DWCZP tablet 100mg.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesSouth Korea
CollaboratorsThe Catholic University of Korea, Konkuk University Hospital, Naju National Hospital, Seoul National Hospital, Wonkwang University, DongGuk University

Timeline

Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 1, 2012
Enrollment StartJun 1, 2012
Primary CompletionApr 1, 2013
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 13.9 years ago

Interventions

DWCZPdrug

Multiple dose

Clozarildrug

multiple-dose